Coherus Biosciences | CHRS - EPS Earnings Per Share

Stock Price
1.99
Daily Change
0.24 13.71%
Monthly
16.37%
Yearly
95.10%
Q2 Forecast
1.71

Coherus Biosciences reported $-0.43 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD -0.4 0.69 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amarin USD 0.14 0.06 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Fujifilm JPY 60.69 5.53 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Myriad Genetics USD -0.09 0.13 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026
Xencor USD -1.71 1.62 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026